SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

NICE Expands IMCIVREE Reimbursement Guidance to Adults With BBS

Eligible adults with genetically confirmed Bardet-Biedl syndrome in England, Wales and Northern Ireland can access setmelanotide through the NHS, extending guidance previously limited to patients aged 6 to 17.

RYTM

Related stories